ImmunityBio Inc’s filing revealed that its Director BLASZYK MICHAEL D acquired Company’s shares for reported $0.2 million on Jun 05 ’23. In the deal valued at $2.75 per share,71,915 shares were bought. As a result of this transaction, BLASZYK MICHAEL D now holds 71,915 shares worth roughly $0.46 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Piper Sandler downgraded its ImmunityBio Inc [IBRX] rating to a Neutral from a an Overweight in a research note published on May 12, 2023; the price target was decreased to $4 from $10. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early August with a ‘”a Buy”‘ rating.
Price Performance Review of IBRX
On Friday, ImmunityBio Inc [NASDAQ:IBRX] saw its stock fall -2.87% to $6.42. Over the last five days, the stock has lost -3.89%. ImmunityBio Inc shares have risen nearly 27.89% since the year began. Nevertheless, the stocks have risen 133.45% over the past one year. While a 52-week high of $10.53 was reached on 04/29/24, a 52-week low of $1.25 was recorded on 01/25/24. SMA at 50 days reached $6.57, while 200 days put it at $4.10. A total of 3.85 million shares were traded, compared to the trading of 3.13 million shares in the previous session.
Levels Of Support And Resistance For IBRX Stock
The 24-hour chart illustrates a support level at 6.21, which if violated will result in even more drops to 5.99. On the upside, there is a resistance level at 6.82. A further resistance level may holdings at 7.21. The Relative Strength Index (RSI) on the 14-day chart is 43.52, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.70, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.64%. Stochastics %K at 6.57% indicates the stock is a buying.
